Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1219759

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1219759

Europe Bioprocess Validation Market Size, Share & Industry Trends Analysis Report By Stage, By Mode, By Testing Type, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 93 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Bioprocess Validation Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).

Process design is the first of the three stages of process validation. In the process design stage, the data from the development phase are gathered and analyzed to define the commercial manufacturing process. By understanding the retail process, a framework for quality specification can be established and utilized as the foundation of a control strategy.

Data from the development phase is collected and analyzed to understand end-to-end system processes. This data is then used for benchmark establishment for production and quality control. In the process qualification stage, the process design is assessed to conclude if the process can meet the determined manufacturing.

All production processes and manufacturing equipment in this stage are proofed to confirm quality & output capabilities. Critical quality attributes are evaluated, while essential parameters of the process are considered to assure the product's quality. Once the process qualification stage has been accomplished, production can be initiated.

UK researchers have played an essential role in scientific endeavors and breakthroughs globally. For instance, the Human genome project, with the UK's Wellcome Sangar Institute leading nearly a third of the effort. The UK has also taught on many ground-breaking world-first research efforts, like the formation of the UK Biobank, the National Institute for Health Research, and the 100,000 genomes project. Building on these capabilities, the nation has developed a core biopharma industry with EUR 36.7 billion annual turnovers and a service and supply chain industry worth EUR 18.4 billion in 2019.

The Germany market dominated the Europe Bioprocess Validation Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $42.1 Million by 2028. The UK market is anticipated to grow at a CAGR of 6.9% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 8.6% during (2022 - 2028).

Based on Stage, the market is segmented into Continued Process Verification, Process Qualification, and Process Design. Based on Mode, the market is segmented into In House and Outsourced. Based on Testing Type, the market is segmented into Bioprocess Residuals Testing, Extractables & Leachables Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Sartorius AG, Merck KGaA, Lonza Group AG, Danaher Corporation, Charles River Laboratories International, Inc., SGS S.A., Labcorp Corporation, and Cobetter Filtration equipment Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Stage

  • Continued Process Verification
  • Process Qualification
  • Process Design

By Mode

  • In House
  • Outsourced

By Testing Type

  • Bioprocess Residuals Testing
  • Extractables & Leachables Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Sartorius AG
  • Merck KGaA
  • Lonza Group AG
  • Danaher Corporation
  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Labcorp Corporation
  • Cobetter Filtration equipment Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Bioprocess Validation Market, by Stage
    • 1.4.2 Europe Bioprocess Validation Market, by Mode
    • 1.4.3 Europe Bioprocess Validation Market, by Testing Type
    • 1.4.4 Europe Bioprocess Validation Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Bioprocess Validation Market

Chapter 4. Europe Bioprocess Validation Market by Stage

  • 4.1 Europe Continued Process Verification Market by Country
  • 4.2 Europe Process Qualification Market by Country
  • 4.3 Europe Process Design Market by Country

Chapter 5. Europe Bioprocess Validation Market by Mode

  • 5.1 Europe In House Market by Country
  • 5.2 Europe Outsourced Market by Country

Chapter 6. Europe Bioprocess Validation Market by Testing Type

  • 6.1 Europe Bioprocess Residuals Testing Market by Country
  • 6.2 Europe Extractables & Leachables Testing Market by Country
  • 6.3 Europe Viral Clearance Testing Market by Country
  • 6.4 Europe Filtration & Fermentation Systems Testing Market by Country
  • 6.5 Europe Others Market by Country

Chapter 7. Europe Bioprocess Validation Market by Country

  • 7.1 Germany Bioprocess Validation Market
    • 7.1.1 Germany Bioprocess Validation Market by Stage
    • 7.1.2 Germany Bioprocess Validation Market by Mode
    • 7.1.3 Germany Bioprocess Validation Market by Testing Type
  • 7.2 UK Bioprocess Validation Market
    • 7.2.1 UK Bioprocess Validation Market by Stage
    • 7.2.2 UK Bioprocess Validation Market by Mode
    • 7.2.3 UK Bioprocess Validation Market by Testing Type
  • 7.3 France Bioprocess Validation Market
    • 7.3.1 France Bioprocess Validation Market by Stage
    • 7.3.2 France Bioprocess Validation Market by Mode
    • 7.3.3 France Bioprocess Validation Market by Testing Type
  • 7.4 Russia Bioprocess Validation Market
    • 7.4.1 Russia Bioprocess Validation Market by Stage
    • 7.4.2 Russia Bioprocess Validation Market by Mode
    • 7.4.3 Russia Bioprocess Validation Market by Testing Type
  • 7.5 Spain Bioprocess Validation Market
    • 7.5.1 Spain Bioprocess Validation Market by Stage
    • 7.5.2 Spain Bioprocess Validation Market by Mode
    • 7.5.3 Spain Bioprocess Validation Market by Testing Type
  • 7.6 Italy Bioprocess Validation Market
    • 7.6.1 Italy Bioprocess Validation Market by Stage
    • 7.6.2 Italy Bioprocess Validation Market by Mode
    • 7.6.3 Italy Bioprocess Validation Market by Testing Type
  • 7.7 Rest of Europe Bioprocess Validation Market
    • 7.7.1 Rest of Europe Bioprocess Validation Market by Stage
    • 7.7.2 Rest of Europe Bioprocess Validation Market by Mode
    • 7.7.3 Rest of Europe Bioprocess Validation Market by Testing Type

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Geographical Expansions:
    • 8.1.6 SWOT Analysis
  • 8.2 Eurofins Scientific SE
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Partnerships, Collaborations, and Agreements:
      • 8.2.4.2 Acquisition and Mergers:
  • 8.3 Sartorius AG
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Merck KGaA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Product Launches and Product Expansions:
  • 8.5 Lonza Group AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
  • 8.6 Danaher Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Charles River Laboratories International, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
  • 8.8 SGS S.A.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
  • 8.9 Labcorp Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
  • 8.10. Cobetter Filtration equipment Co., Ltd.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 3 Europe Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 4 Europe Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 5 Europe Continued Process Verification Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Europe Continued Process Verification Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Europe Process Qualification Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Europe Process Qualification Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Europe Process Design Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Process Design Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 12 Europe Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 13 Europe In House Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Europe In House Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Europe Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 18 Europe Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 19 Europe Bioprocess Residuals Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Europe Bioprocess Residuals Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Europe Extractables & Leachables Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Europe Extractables & Leachables Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Europe Viral Clearance Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Europe Viral Clearance Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Europe Filtration & Fermentation Systems Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Europe Filtration & Fermentation Systems Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Europe Bioprocess Validation Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Europe Bioprocess Validation Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Germany Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 32 Germany Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 33 Germany Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 34 Germany Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 35 Germany Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 36 Germany Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 37 Germany Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 38 Germany Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 39 UK Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 40 UK Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 41 UK Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 42 UK Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 43 UK Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 44 UK Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 45 UK Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 46 UK Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 47 France Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 48 France Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 49 France Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 50 France Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 51 France Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 52 France Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 53 France Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 54 France Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 55 Russia Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 56 Russia Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 57 Russia Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 58 Russia Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 59 Russia Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 60 Russia Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 61 Russia Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 62 Russia Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 63 Spain Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 64 Spain Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 65 Spain Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 66 Spain Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 67 Spain Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 68 Spain Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 69 Spain Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 70 Spain Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 71 Italy Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 72 Italy Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 73 Italy Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 74 Italy Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 75 Italy Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 76 Italy Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 77 Italy Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 78 Italy Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 79 Rest of Europe Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 80 Rest of Europe Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 81 Rest of Europe Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 82 Rest of Europe Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 83 Rest of Europe Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 84 Rest of Europe Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 85 Rest of Europe Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 86 Rest of Europe Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 87 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 88 Key Information - Eurofins Scientific SE
  • TABLE 89 KEY INFORMATION - Sartorius AG
  • TABLE 90 key Information - Merck KGaA
  • TABLE 91 Key Information - Lonza Group AG
  • TABLE 92 Key Information - Danaher Corporation
  • TABLE 93 key information - Charles River Laboratories International, Inc.
  • TABLE 94 Key Information - SGS S.A.
  • TABLE 95 Key Information - Labcorp corporation
  • TABLE 96 Key Information - Cobetter filtration equipment co., ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Swot analysis: thermo fisher scientific, inc.
  • FIG 3 Recent strategies and developments: Sartorius AG
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!